SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Cancer vaccine-maker MabVax Therapeutics Holdings Inc. reported a net loss of $6.4 million in the second quarter of this year, up from $2.4 million in the same period last year.
A wholly owned subsidiary of Sorrento Therapeutics Inc. has acquired multiple preclinical and clinical stage chimeric antigen receptor immunotherapy programs as well as underlying CAR-T technology.
Conatus Pharmaceuticals Inc., a biotech focused on the development and commercialization of liver disease drugs, announced financial results Friday for the second quarter.
Poseida Therapeutics Inc., a therapeutics spin out of Transposagen Biopharmaceuticals Inc., announced the appointment of Dr. Lars Ekman and Dr. Nishan de Silva to the company's Board of Directors.
A donation from medical device maker ResMed Inc. is being used to launch a program in San Diego to prepare low-income students for the left-brain jobs that dominate the local economy.
San Diego-based MabVax Therapeutics Holdings Inc., an oncology company working on cancer vaccines, has entered into a research collaboration with The Rockefeller University.
BIOTECH: Its Alzheimer’s Program Will Be Revamped
Leaders at the University of California, San Diego’s medical school are brainstorming ways to safeguard the university’s reputation in response to an ongoing legal dispute that gets uglier by the day.
AMN Healthcare Services stock hit a new 52-week high during mid-day trading on Wednesday following a stronger than expected earnings report.
Ligand Pharmaceuticals Inc. announced the appointment of Matthew Korenberg as vice president of finance and chief financial officer effective Aug. 6.
AmpliPhi BioSciences Corp. announced Tuesday that its board of directors has approved a 1-for-50 reverse stock split to become effective at the market's opening on August 7.
Construction has begun on a new 100,000-square-foot building off Interstate 15, where healthcare services provider Sharp Rees-Stealy will be relocating its Rancho Bernardo branch operations.
Isis Pharmaceuticals Inc. reported net income of $35.6 million for the second quarter, compared to a net loss of $12.1 million for the same period last year.
Isis Pharmaceuticals is expanding its reach into even more drug areas after signing another major drug development partnership with AstraZeneca, bringing the Carlsbad biotech $65 million upfront.
Rancho Bernardo-based Millennium Health had its credit rating downgraded by rating agency Moody’s, the second time in five weeks that the outlook for the nation’s largest drug-testing company has slipped.
Medical device firm ResMed is set to expand in China and says it remains on track to meet its 2020 goals after a lift in its fourth-quarter revenues, according to recent financial statements.